Multiple Myeloma - A New Era of Treatment Strategies

Indexed in: Book Citation Index, Science Edition (BKCI-S), Web of Science, Scopus, EBSCO.

Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Mouse Models of Multiple Myeloma: Advantages and Pitfalls

Pp. 149-160 (12)

DOI: 10.2174/978160805297411201010149

Author(s): Mariateresa Fulciniti, Paola Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone


Multiple myeloma (MM) is a complex disease which strongly relies on a network of humoral and cellular interactions within the human bone marrow milieu. Although outcomes of anti-MM treatments have improved over the past decade, the disease is still incurable. Translational research for the development of novel therapeutic approaches against MM requires experimental preclinical models able to recapitulate the disease microenvironment. Over the last few years, a variety of murine MM models have been developed. These models have significantly improved our understanding of the disease and led to the development of new therapeutics. We here review the most known models of MM and discuss both advantages and pitfalls.


Xenograft mouse models, diffuse xenograft mouse models, SCID mouse, SCID-hu mouse, SCID rab mouse, NOD/SCID mouse, 5TMM, VK* myc, LAG-1 model.